GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Cyclically Adjusted PS Ratio

Faes Farma (XMAD:FAE) Cyclically Adjusted PS Ratio : 2.65 (As of Jun. 13, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Faes Farma Cyclically Adjusted PS Ratio?

As of today (2024-06-13), Faes Farma's current share price is €3.77. Faes Farma's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.42. Faes Farma's Cyclically Adjusted PS Ratio for today is 2.65.

The historical rank and industry rank for Faes Farma's Cyclically Adjusted PS Ratio or its related term are showing as below:

XMAD:FAE' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.04   Med: 2.99   Max: 4.95
Current: 2.6

During the past years, Faes Farma's highest Cyclically Adjusted PS Ratio was 4.95. The lowest was 2.04. And the median was 2.99.

XMAD:FAE's Cyclically Adjusted PS Ratio is ranked worse than
59.27% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.055 vs XMAD:FAE: 2.60

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Faes Farma's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.447. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.42 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Faes Farma Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Faes Farma's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Cyclically Adjusted PS Ratio Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.57 3.12 2.81 2.60 -

Faes Farma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.60 2.23 2.26 - 2.21

Competitive Comparison of Faes Farma's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Faes Farma's Cyclically Adjusted PS Ratio falls into.



Faes Farma Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Faes Farma's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.77/1.42
=2.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Faes Farma's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.447/122.7621*122.7621
=0.447

Current CPI (Mar. 2024) = 122.7621.

Faes Farma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.000 100.139 0.000
201406 0.021 101.081 0.026
201409 0.001 100.441 0.001
201412 0.774 100.251 0.948
201503 0.000 99.474 0.000
201506 0.004 101.138 0.005
201509 0.018 99.559 0.022
201512 0.783 100.268 0.959
201603 0.000 98.638 0.000
201606 0.004 100.333 0.005
201609 0.646 99.737 0.795
201612 0.225 101.842 0.271
201703 0.229 100.896 0.279
201706 0.246 101.848 0.297
201709 0.272 101.524 0.329
201712 0.283 102.975 0.337
201803 0.011 102.122 0.013
201806 0.589 104.165 0.694
201809 -0.557 103.818 -0.659
201812 1.132 104.193 1.334
201903 0.016 103.488 0.019
201906 0.608 104.612 0.713
201909 0.371 103.905 0.438
201912 0.245 105.015 0.286
202003 0.420 103.469 0.498
202006 0.271 104.254 0.319
202009 0.394 103.521 0.467
202012 0.220 104.456 0.259
202103 0.345 104.857 0.404
202106 0.287 107.102 0.329
202109 0.423 107.669 0.482
202112 0.255 111.298 0.281
202203 0.393 115.153 0.419
202206 0.333 118.044 0.346
202209 0.381 117.221 0.399
202212 0.273 117.650 0.285
202303 0.409 118.948 0.422
202306 0.338 120.278 0.345
202312 0.000 121.300 0.000
202403 0.447 122.762 0.447

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Faes Farma  (XMAD:FAE) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Faes Farma Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Faes Farma's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma (XMAD:FAE) Business Description

Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (XMAD:FAE) Headlines

No Headlines